Changes in the quality of life of people with thalassemia major between 2001 and 2009

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 231-236

  Gollo, Giorgia ^a   Savioli, Gaia ^b   Balocco, Manuela ^b   Venturino, Cristina ^b   Boeri, Elio ^c   Costantini, Massimo ^a   Forni, Gian Luca ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Quality of life; Short Form 36; Survey; Thalassemia major

Indexed keywords

DEFERASIROX; DEFERIPRONE; FERRITIN;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEART DISEASE; HUMAN; ITALY; MALE; MENTAL COMPONENT SUMMARY SCALE; MENTAL HEALTH; MENTAL HEALTH SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SHORT FORM 36; THALASSEMIA MAJOR;

EID: 84875417395     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S42133     Document Type: Article

References (23)

1. Telfer P. Update on survival in thalassemia major. Hemoglobin. 2009;33 Suppl 1:S76-S80.
2. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187-1193.
3. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.
4. Forni GL, Puntoni M, Boeri E, Terenzani L, Balocco M. The influence of treatment in specialized centers on survival of patients with thalassemia major. Am J Hematol. 2009;84:317-318.
5. Galanello R. A thalassemic child becomes adult. Rev Clin Exp Hematol. 2003;7:4-21.
6. Musallam K, Cappellini MD, Taher A. Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthood. Pediatrics. 2008;121:e1426-e1429.
7. Anie KA, Massaglia P. Psychological therapies for thalassaemia. Cochrane Database Syst Rev. 2001;3:CD002890.
8. Messina G, Colombo E, Cassinerio E, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med. 2008;3:339-343.
9. Payne KA, Rofail D, Baladi JF, et al. Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload. Adv Ther. 2008;25:725-742.
10. Mikelli A, Tsiantis JJ. Depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004;27:213-216.
11. Telfer P, Coen PG, Christou S, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica. 2006;91:1187-1192.
12. Di Palma A, Vullo C, Zani B, Facchini A. Psychosocial integration of adolescents and young adults with thalassemia major. Ann N Y Acad Sci. 1998;850:355-360.
13. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36); conceptual framework and item selection. Med Care. 1992;30:473-483.
14. Ware JE Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1167-1170.
15. Ware JE, Keller SD, Gandek B, Brazier JE, Sullivan M. IQOLA Project Group. Evaluating translations of health status questionnaires: methods from IQOLA project. Int J Technol Assess Health Care. 1995;11:525-551.
16. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998;51:1025-1036.
17. Sobota A, Yamashita R, Xu Y, et al. Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. Am J Hematol. 2011;86: 92-95.
18. Mednick L, Yu S, Trachtenberg F, et al. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;85:802-805.
19. Khani H, Majdi MR, Azad Marzabadi E, Montazeri A, Ghorbani A, Ramezani M. Quality of life of Italian β-thalassemia major patients living on the southern coast of the Caspian Sea. East Mediterr Health J. 2012;18:539-545.
20. Masera G, Monguzzi W, Tornotti G, Lo Iacono B, Pertici S, Spinetta J. Psychosocial support in thalassemia major: Monza center's experience. Haematologica. 1990;75 Suppl 5:181-190.
21. Mazzone L, Battaglia L, Andreozzi F, Romeo MA, Mazzone D. Emotional impact in beta-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers. Clin Pract Epidemiol Ment Health. 2009;5:5-10.
22. Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054:273-282.
23. Editorial. Pain control-a basic kindness. Lancet. 2012;379:2024.